Cerebroventricular size and cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy volunteers-Reference-Cited by-同舟云学术

Cerebroventricular size and cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy volunteers

Published:1983-08 Issue:4 Volume:9 Page:301-308
ISSN:0165-1781
Container-title:Psychiatry Research
language:en
Short-container-title:Psychiatry Research

Author:

Nybäck Henrik,Berggren Britt-Marie,Hindmarsh Tomas,Sedvall Göran,Wiesel Frits-Axel

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference40 articles.

1. Effects of chlorpromazine, haloperidol, and reserpine on levels of phenolic acids in rabbit corpus striatum;Andén;Life Sciences,1964

2. 5-Hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases;Ashcroft;Lancet,1966

3. Central dopamine turnover in schizophrenic syndromes;Bowers;Archives of General Psychiatry,1974

4. Dopaminergic neurons: Effects of antipsychotic drugs and amphetamine on single cell activity;Bunney;Journal of Pharmacology and Experimental Therapeutics,1973

5. CT scan variants and genetic heterogeneity in schizophrenia;Campbell;American Journal of Psychiatry,1979

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetic Regulation in Schizophrenia: Focus on Methylation and Histone Modifications in Human Studies;Genes;2024-02-21

2. CSF dopamine is elevated in first-episode psychosis and associates to symptom severity and cognitive performance;Schizophrenia Research;2023-07

3. Biomarkers in the cerebrospinal fluid of patients with psychotic disorders compared to healthy controls: a systematic review and meta-analysis;Molecular Psychiatry;2023-05-11

4. Neuromelanin accumulation in patients with schizophrenia: A systematic review and meta-analysis;Neuroscience & Biobehavioral Reviews;2022-01

5. A New Look on an Old Issue: Comprehensive Review of Neurotransmitter Studies in Cerebrospinal Fluid of Patients with Schizophrenia and Antipsychotic Effect on Monoamine's Metabolism;Clinical Psychopharmacology and Neuroscience;2021-08-31